Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07755150
What this trial is testing

Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Chendu DIAO Pharmaceutical Group CO., LTD. 272
Early research (Phase 1)Study completedNCT01082120
What this trial is testing

Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 28
Early research (Phase 1)Study completedNCT00989079
What this trial is testing

A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 24
Early research (Phase 1)Study completedNCT06498284
What this trial is testing

Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type II
Hua Medicine Limited 40
Testing effectiveness (Phase 2)Study completedNCT01756716
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 49
Early research (Phase 1)Study completedNCT04575181
What this trial is testing

A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 86
Testing effectiveness (Phase 2)Study completedNCT05013008
What this trial is testing

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 951
Not applicableStudy completedNCT01666223
What this trial is testing

Effect of Bile Acids on GLP-1 Secretion

Who this might be right for
Type 2 DiabetesObesity
University Hospital, Gentofte, Copenhagen 20
Testing effectiveness (Phase 2)Study completedNCT00539396
What this trial is testing

A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

Who this might be right for
Diabetes Mellitus, Type 1
Mannkind Corporation 110
Not applicableStudy completedNCT03127696
What this trial is testing

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Who this might be right for
Type2 DiabetesType 2 Diabetes MellitusObese
Chinese University of Hong Kong 61
Early research (Phase 1)Study completedNCT02940379
What this trial is testing

A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 24
Early research (Phase 1)Ended earlyNCT00726505
What this trial is testing

Renal Mechanism of Action/Splay vs. TmG

Who this might be right for
Diabetes, NOS
AstraZeneca 1
Not applicableStudy completedNCT00418288
What this trial is testing

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia

Who this might be right for
Type 2 DiabetesStrokeMyocardial Infarction
University of Aarhus 10
Early research (Phase 1)Study completedNCT02354027
What this trial is testing

The Drug-drug Interaction of SHR3824 and Metformin

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 12
Not applicableEnded earlyNCT03072901
What this trial is testing

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

Who this might be right for
Type 2 DiabetesObesity
Morphic Medical Inc. 244
Large-scale testing (Phase 3)Study completedNCT02863328
What this trial is testing

Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 822
Large-scale testing (Phase 3)Study completedNCT00423488
What this trial is testing

Ezetimibe and Simvastatin in Primary Hypercholesterolemia, Diabetes Mellitus Type 2, and Coronary Heart Disease (COMPLETED)

Who this might be right for
HypercholesterolemiaDiabetes Mellitus, Type 2Coronary Disease
Organon and Co 93
Not applicableStudy completedNCT00550329
What this trial is testing

Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHyperglycemia
Pfizer 32
Large-scale testing (Phase 3)Study completedNCT00627445
What this trial is testing

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 441
Large-scale testing (Phase 3)Study completedNCT00521742
What this trial is testing

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

Who this might be right for
Diabetes Mellitus
Takeda 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation